Cargando…

Meeting report: 34th international conference on antiviral research

As a result of the multiple gathering and travels restrictions during the SARS-CoV-2 pandemic, the annual meeting of the International Society for Antiviral Research (ISAR), the International Conference on Antiviral Research (ICAR), could not be held in person in 2021. Nonetheless, ISAR successfully...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brancale, Andrea, Carter, Kara, Delang, Leen, Deval, Jerome, Durantel, David, Gentry, Brian G, Jordan, Robert, Julander, Justin G., Lo, Michael K., Pérez-Pérez, Maria-Jesús, Schang, Luis M., Seley-Radtke, Katherine L., Shi, Pei-Yong, Vasudevan, Subhash G., Whitley, Richard J., Spengler, Jessica R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Meeting Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623364/ https://www.ncbi.nlm.nih.gov/pubmed/36305015 http://dx.doi.org/10.1177/20402066221130853

Ejemplares similares

Advances in antiviral nucleoside analogues and their prodrugs
por: Seley-Radtke, Katherine, et al.
Publicado: (2018)

Meeting report: 32nd International Conference on Antiviral Research
por: Tramontano, Enzo, et al.
Publicado: (2019)

Small molecule antivirals – Still our best hope for a cure
por: Seley-Radtke, Katherine
Publicado: (2020)

Antiviral Strategies against Arthritogenic Alphaviruses
por: Abdelnabi, Rana, et al.
Publicado: (2020)

Towards antivirals against chikungunya virus
por: Abdelnabi, Rana, et al.
Publicado: (2015)

Antiviral Strategies Against Chikungunya Virus
por: Abdelnabi, Rana, et al.
Publicado: (2015)

Antiviral Therapy for Hepatitis C Virus: Beyond the Standard of Care
por: Delang, Leen, et al.
Publicado: (2010)

Broad spectrum antiviral nucleosides—Our best hope for the future
por: Seley-Radtke, Katherine L., et al.
Publicado: (2021)

The evolution of antiviral nucleoside analogues: A review for chemists and non-chemists. Part II: Complex modifications to the nucleoside scaffold
por: Yates, Mary K., et al.
Publicado: (2019)

The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold
por: Seley-Radtke, Katherine L., et al.
Publicado: (2018)

Meeting report: 31(st) International Conference on Antiviral Research
por: Bray, Mike, et al.
Publicado: (2018)

Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses
por: Eyer, Luděk, et al.
Publicado: (2018)

Novel 1-[5-(4-bromophenoxy)pentyl]-3-(2-arylamino- 2-oxoethyl)uracils and their antiviral properties
por: Paramonova, Maria P., et al.
Publicado: (2017)

Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by Aedes Mosquitoes
por: Delang, Leen, et al.
Publicado: (2018)

Flexibility—Not just for yoga anymore!
por: Seley-Radtke, Katherine
Publicado: (2018)

Discovery, Design, Synthesis, and Application of Nucleoside/Nucleotides
por: Seley-Radtke, Katherine
Publicado: (2020)

Preface
por: Seley-Radtke, Katherine
Publicado: (2021)

Highlights of the 30th International Conference on Antiviral Research
por: Andrei, Graciela, et al.
Publicado: (2017)

Innovation and trends in the development and approval of antiviral medicines: 1987–2017 and beyond
por: Chaudhuri, Shuvam, et al.
Publicado: (2018)

Probing the Effects of Pyrimidine Functional Group Switches on Acyclic Fleximer Analogues for Antiviral Activity
por: Yates, Mary K., et al.
Publicado: (2019)

In Vitro Characterization and Antiviral Susceptibility of Ophidian Serpentoviruses
por: Tillis, Steven B., et al.
Publicado: (2023)

Recent advances in synthetic approaches for medicinal chemistry of C-nucleosides
por: Temburnikar, Kartik, et al.
Publicado: (2018)

Medical treatment options for COVID-19
por: Delang, Leen, et al.
Publicado: (2020)

Culex modestus: the overlooked mosquito vector
por: Soto, Alina, et al.
Publicado: (2023)

Antivirals in medical biodefense
por: Bugert, J. J., et al.
Publicado: (2020)

Structural biology in antiviral drug discovery
por: Bassetto, Marcella, et al.
Publicado: (2016)

Innate Antiviral Immune Responses to Hepatitis B Virus
por: Ait-goughoulte, Malika, et al.
Publicado: (2010)

Structure activity relationship of novel antiviral nucleosides against Enterovirus A71
por: Tosh, Dilip K., et al.
Publicado: (2020)

An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral
por: Julander, Justin G., et al.
Publicado: (2021)

Modifications in the branched arms of a class of dual inhibitors of HIV and EV71 replication expand their antiviral spectrum
por: Martínez-Gualda, Belén, et al.
Publicado: (2019)

The role of phosphatidylinositol 4-kinases and phosphatidylinositol 4-phosphate during viral replication
por: Delang, Leen, et al.
Publicado: (2012)

Synthesis and biological evaluation of novel flexible nucleoside analogues that inhibit flavivirus replication in vitro
por: Thames, Joy E., et al.
Publicado: (2020)

Repurposing Drugs for Mayaro Virus: Identification of EIDD-1931, Favipiravir and Suramin as Mayaro Virus Inhibitors
por: Langendries, Lana, et al.
Publicado: (2021)

Application of the phosphoramidate ProTide approach to the antiviral drug ribavirin
por: Derudas, Marco, et al.
Publicado: (2010)

Chromatin-mediated epigenetic regulation of HSV-1 transcription as a potential target in antiviral therapy
por: Schang, Luis M., et al.
Publicado: (2021)

Synthesis of 3-hetarylpyrroles by Suzuki–Miyaura cross-coupling
por: Matyugina, Elena S., et al.
Publicado: (2020)

Nucleosides for the treatment of respiratory RNA virus infections
por: Jordan, Paul C, et al.
Publicado: (2018)

Antiviral T‐cell therapy
por: Leen, Ann M., et al.
Publicado: (2014)

Synthesis and in vitro antiviral evaluation of 4-substituted 3,4-dihydropyrimidinones
por: Kumarasamy, Dhanabal, et al.
Publicado: (2017)

Novel Nucleoside Analogues as Effective Antiviral Agents for Zika Virus Infections
por: Bassetto, Marcella, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5j0fjhgk8uatse8r4nue3ovu20